InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（2 笔）
内部人交易记录
董事已披露买入
1
已披露卖出
2
T+90 胜率
0%
T+90 平均收益
-59.2%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Browse the detailed record of transactions filed by Herskowitz Neil, 董事. Insider active across 4 companies, notably Avenue Therapeutics, INC.. In total, 20 filings have been logged. Split: 1 buy · 2 sells. Total volume traded: €9k. Activity tracked since 6 May 2021. The latest transaction was filed on 30 December 2025 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Herskowitz Neil
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报20 总计
10,000 股Common Stock, $0.0001 par valueSEC:0001104659-26-078282:0
247 股@ US$0.962100.0% 占其流量COMMON STOCK, PAR VALUE $0.0001SEC:0001104659-25-125233:0
20,000 股0Common Stock, $0.0001 par valueSEC:0001104659-25-075260:0
7,173 股0Common Stock, $0.0001 par valueSEC:0001104659-25-066236:0
12,195 股0COMMON STOCKSEC:0001104659-25-054688:0
17,638 股0COMMON STOCKSEC:0001104659-24-129522:0
23 股@ US$2.000.3% 占其流量COMMON STOCK, PAR VALUE $0.0001SEC:0001104659-24-125093:0
9,728 股0Common Stock, $0.0001 par valueSEC:0001104659-24-078972:0
32,051 股0COMMON STOCKSEC:0001104659-24-062663:0
27,472 股0Common Stock, par value $0.0001 per shareSEC:0001104659-23-083836:0
7,246 股0COMMON STOCK, PAR VALUE $0.0001SEC:0001104659-23-079111:0
17,483 股0COMMON STOCKSEC:0001104659-23-071758:0
71,664 股0COMMON STOCK, PAR VALUE $0.0001SEC:0001104659-23-040929:0
14,245 股0Common Stock, par value $0.0001 per shareSEC:0001104659-22-082288:0
47,619 股0COMMON STOCKSEC:0001104659-22-074467:0
30,000 股0COMMON STOCKSEC:0001104659-22-042276:0
49,020 股0Common StockSEC:0001104659-21-152198:0
13,774 股0COMMON STOCKSEC:0001104659-21-090240:0
16,502 股0COMMON STOCKSEC:0001104659-21-080361:0
2,500 股@ US$3.9999.5% 占其流量Common StockSEC:0001104659-21-062774:0
标准退出：2021年8月4日 (T+90)
20 条申报中的 20 条
About Herskowitz Neil
Herskowitz Neil is Administrateur and a director of Journey Medical Corp, Checkpoint Therapeutics, Inc., Mustang Bio, INC. and Avenue Therapeutics, INC. Across 20 filings in total, the 20 sampled filings run from 2021-05-07 to 2026-06-26, with EUR 8265 of buys and EUR 245 of sells, and the most frequent transaction nature is Attribution.
